A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
The Hippo/Yap signalling pathway is found deregulated in several cancers. Here, the authors uncover an additional mechanism of YAP regulation that occurs via alternately spliced isoform of TEAD4, which acts as a dominant negative regulator of YAP-TEAD signalling.
Guardado en:
Autores principales: | Yangfan Qi, Jing Yu, Wei Han, Xiaojuan Fan, Haili Qian, Huanhuan Wei, Yi-hsuan S. Tsai, Jinyao Zhao, Wenjing Zhang, Quentin Liu, Songshu Meng, Yang Wang, Zefeng Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8a4ec7f1fc64a198fd124141bb70228 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
por: Nicholas Van Sciver, et al.
Publicado: (2021) -
Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
por: Hung Yi Kristal Kaan, et al.
Publicado: (2017) -
The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Linda Shyue Huey Chuang, et al.
Publicado: (2021) -
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
por: Dana Elster, et al.
Publicado: (2018) -
PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2
por: Yue Chang, et al.
Publicado: (2021)